Steven Cohen Vera Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 194,027 shares of VERA stock, worth $5.17 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
194,027
Previous 171,573
13.09%
Holding current value
$5.17 Million
Previous $7.58 Million
8.23%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
192Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$149 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$117 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$88.9 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$78.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$78.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $720M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...